Literature DB >> 34994155

CFTR deficiency aggravates Ang II induced vasoconstriction and hypertension by regulating Ca2+ influx and RhoA/Rock pathway in VSMCs.

Liyan Zhao1,2, Feng Yuan2, Ni Pan2, Yun Yu3, Hanyan Yang2, Yaosheng Liu2, Ruomei Wang4, Bin Zhang5, Guanlei Wang2.   

Abstract

BACKGROUND: Cystic fibrosis transmembrane conductance regulator (CFTR) has been associated with vascular tone and blood pressure (BP), however, its role in the genesis of hypertension remains elusive. In the present study, we investigated the regulating effect of CFTR on angiotensin II (Ang II) -induced hypertension and defined the molecular role of CFTR in vasoconstriction.
RESULTS: We found that CFTR mRNA and protein expression were markedly down-regulated in the arteries from Ang II induced hypertensive animals. During the development of hypertension, BP of Cftr-⁣/- mice was significantly higher than that of Cftr+⁣/+ mice. Arteries from Cftr-⁣/- mice or pre-incubated with CFTR specific inhibitor CFTR(inh)-172 exhibited a greater contractile response to Ang II. In vascular smooth muscle cells (VSMCs), the phosphorylation of myosin light chain (MLC), which is the core of VSMCs contraction, was negatively modulated by CFTR. Furthermore, intracellular Ca2+ concentration ([Ca2+]i) rise in response to Ang II was negatively modulated by CFTR, while no alteration was observed in resting VSMCs. Ras homolog family member A/Rho-associated protein kinase (RhoA/Rock) mediated phosphorylation of myosin phosphatase target subunit 1 (MYPT1), a regulator of MLC phosphorylation, was negatively modulated by CFTR in both resting and Ang II-stimulated VSMCs.
CONCLUSIONS: This study demonstrates that CFTR is a negative regulator of vasoconstriction and hypertension, and the underlying mechanism contains two possible pathways: (1) in resting VSMCs, CFTR altered MLC phosphorylation through RhoA/Rock pathway; (2) in Ang II stimulated VSMCs, the regulating effect was mediated by both Ca2+ influx and RhoA/Rock mediated pathway.
© 2021 The Author(s). Published by BRI.

Entities:  

Keywords:  CFTR; Ca2+; Hypertension; RhoA; Vascular smooth muscle cells; Vasoconstriction

Mesh:

Substances:

Year:  2021        PMID: 34994155     DOI: 10.52586/5034

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  2 in total

1.  CFTR Suppresses Neointimal Formation Through Attenuating Proliferation and Migration of Aortic Smooth Muscle Cells.

Authors:  Liu-Yi Lu; Ni Pan; Ze-Han Huang; Jing-Song Wang; Yong-Bo Tang; Hong-Shuo Sun; Hui Han; Han-Yan Yang; Jun-Zhen Zhu; Yong-Yuan Guan; Bin Zhang; Dong-Zhi Li; Guan-Lei Wang
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

2.  Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters.

Authors:  Benoît Chevalier; Nesrine Baatallah; Matthieu Najm; Solène Castanier; Vincent Jung; Iwona Pranke; Anita Golec; Véronique Stoven; Stefano Marullo; Fabrice Antigny; Ida Chiara Guerrera; Isabelle Sermet-Gaudelus; Aleksander Edelman; Alexandre Hinzpeter
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.